|
Volumn 44, Issue 1 SUPPL., 2001, Pages
|
Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, safety
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHISTAMINIC AGENT;
ANTIMIGRAINE AGENT;
ASTEMIZOLE;
CORTICOSTEROID;
HISTAMINE H1 RECEPTOR ANTAGONIST;
HISTAMINE H2 RECEPTOR ANTAGONIST;
IMMUNOSUPPRESSIVE AGENT;
PREDNISONE;
STEROID;
TACROLIMUS;
TERFENADINE;
ACNE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
ATOPIC DERMATITIS;
BACKACHE;
BODY SURFACE;
BURN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYST;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
ERYTHEMA;
FEMALE;
FLU LIKE SYNDROME;
FOLLICULITIS;
HEADACHE;
HUMAN;
HYPERESTHESIA;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
MYALGIA;
OINTMENT;
PRIORITY JOURNAL;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
RASH;
SINUSITIS;
SKIN INFECTION;
SKIN TINGLING;
|
EID: 0035157895
PISSN: 01909622
EISSN: None
Source Type: Journal
DOI: 10.1067/mjd.2001.109817 Document Type: Article |
Times cited : (250)
|
References (36)
|